HFA Launches New End-of-Life Dementia Care Training

Why It Matters

As dementia patients become a larger share of hospice caseloads, targeted training can improve care quality, reduce live discharges, and support families during end‑of‑life transitions.

Key Takeaways

• 33% of hospice decedents had dementia diagnosis (2016‑2019)
• HFA's program offers CE credits for interdisciplinary hospice teams
• Training addresses caregiver burnout, live discharges, and bereavement
• Focus on culturally sensitive communication and goal‑concordant care
• Longer hospice stays and higher live discharge rates linked to ADRD

Pulse Analysis

The aging of America’s population is accelerating the prevalence of Alzheimer’s disease and related dementias (ADRD), and hospice providers are feeling the pressure. Between 2016 and 2019, roughly one‑third of Medicare hospice decedents carried an ADRD diagnosis, a figure that translates into longer average stays and a higher incidence of live discharges compared with non‑dementia patients. Traditional hospice reimbursement structures were not designed for the prolonged, nuanced trajectory of dementia, leaving many facilities scrambling to meet both clinical and emotional needs of patients and families.

In response, the Hospice Foundation of America introduced the Best Practices in Hospice Care for Advanced Dementia program, a comprehensive, credit‑bearing curriculum aimed at interdisciplinary teams. The training delves into practical strategies for managing behavioral symptoms, navigating pharmaceutical challenges, and conducting anticipatory grief conversations. It also emphasizes culturally responsive care, family caregiver support, and community engagement, giving clinicians concrete tools to align treatment plans with patients’ values and preferences. By awarding continuing‑education credits, HFA incentivizes participation and helps organizations meet professional development requirements while elevating care standards.

The broader impact of this initiative could reshape hospice quality metrics and reimbursement discussions. As providers adopt the program’s evidence‑based approaches, they may see reductions in live discharge rates and improvements in patient‑family satisfaction scores—key indicators for Medicare and private payers. Moreover, the emphasis on early advance‑care planning and sustained caregiver education could lower downstream costs associated with emergency interventions and hospital readmissions. For the hospice industry, embracing dementia‑focused training is becoming not just a best practice but a competitive necessity in a market where the proportion of ADRD patients will only continue to rise.